Total Payments
$560.50
2024 Payments
$109.66
Companies
10
Transactions
27
Medicare Patients
9,325
Medicare Billing
$533,494
Payment Breakdown by Category
Food & Beverage$560.50 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $560.50 | 27 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $234.58 | 13 | $0 (2024) |
| Boston Scientific Corporation | $84.31 | 2 | $0 (2023) |
| Genentech USA, Inc. | $51.68 | 3 | $0 (2020) |
| Hologic Sales and Service, LLC | $46.23 | 2 | $0 (2024) |
| PFIZER INC. | $33.27 | 2 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $29.66 | 1 | $0 (2023) |
| Hologic, LLC | $25.36 | 1 | $0 (2022) |
| Melinta Therapeutics, Inc. | $22.06 | 1 | $0 (2018) |
| Hikma Pharmaceuticals USA | $21.34 | 1 | $0 (2024) |
| Optinose US, Inc. | $12.01 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $109.66 | 5 | GlaxoSmithKline, LLC. ($49.83) |
| 2023 | $198.31 | 7 | Boston Scientific Corporation ($84.31) |
| 2022 | $25.36 | 1 | Hologic, LLC ($25.36) |
| 2021 | $66.05 | 4 | GlaxoSmithKline, LLC. ($66.05) |
| 2020 | $44.56 | 3 | GlaxoSmithKline, LLC. ($28.72) |
| 2019 | $35.84 | 2 | Genentech USA, Inc. ($35.84) |
| 2018 | $80.72 | 5 | GlaxoSmithKline, LLC. ($46.65) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/13/2024 | Hologic Sales and Service, LLC | APTIMA (Device), THINPREP 2000 PROCESSOR | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Diagnostics | ||||||
| 08/08/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 06/19/2024 | Hikma Pharmaceuticals USA | Ryaltris (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 05/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: RESPIRATORY | ||||||
| 01/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: RESPIRATORY | ||||||
| 09/07/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $29.66 | General |
| 05/22/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: RESPIRATORY | ||||||
| 05/19/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/17/2023 | Hologic Sales and Service, LLC | AFFIRM PRONE BIOPSY SYSTEM (Device), THINPREP 2000 PROCESSOR | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Breast and Skeletal Health | ||||||
| 03/30/2023 | Boston Scientific Corporation | Superion Indirect Decompression System (Device) | Food and Beverage | In-kind items and services | $44.38 | General |
| Category: Vertiflex Superion_NMD | ||||||
| 01/04/2023 | Boston Scientific Corporation | Superion Indirect Decompression System (Device) | Food and Beverage | In-kind items and services | $39.93 | General |
| Category: Vertiflex Superion_NMD | ||||||
| 08/24/2022 | Hologic, LLC | THINPREP 2000 PROCESSOR (Device), APTIMA | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: Diagnostics | ||||||
| 11/19/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: RESPIRATORY | ||||||
| 08/02/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: RESPIRATORY | ||||||
| 06/11/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: RESPIRATORY | ||||||
| 03/04/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: RESPIRATORY | ||||||
| 12/23/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Virology & Specialty Care | ||||||
| 11/25/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: RESPIRATORY | ||||||
| 07/15/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Virology & Specialty Care | ||||||
| 01/30/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Virology & Specialty Care | ||||||
| 09/05/2018 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/11/2018 | Melinta Therapeutics, Inc. | Baxdela (Drug), Vabomere, Orbactiv | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/10/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 409 | 678 | $54,568 | $25,791 |
| 2022 | 12 | 582 | 761 | $101,900 | $48,196 |
| 2021 | 43 | 4,573 | 5,192 | $748,638 | $268,194 |
| 2020 | 41 | 3,761 | 4,113 | $610,701 | $191,313 |
Total Patients
9,325
Total Services
10,744
Medicare Billing
$533,494
Procedure Codes
109
All Medicare Procedures & Services
109 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $15,345 | $7,478 | 48.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 67 | $14,539 | $7,080 | 48.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 45 | $6,885 | $3,211 | 46.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 37 | 37 | $6,919 | $3,139 | 45.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 47 | 51 | $5,100 | $1,766 | 34.6% |
| 87400 | Detection test by immunoassay technique for influenza virus | Office | 2023 | 40 | 86 | $1,978 | $1,191 | 60.2% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 22 | 24 | $1,416 | $704.60 | 49.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 40 | $1,000 | $484.25 | 48.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 24 | 24 | $648.00 | $388.80 | 60.0% |
| 87420 | Detection test by immunoassay technique for respiratory syncytial virus (rsv) | Office | 2023 | 17 | 18 | $414.00 | $245.34 | 59.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 25 | 31 | $124.00 | $68.20 | 55.0% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 12 | 56 | $56.00 | $21.82 | 39.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 15 | 144 | $144.00 | $14.10 | 9.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 111 | 111 | $31,040 | $18,130 | 58.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 62 | 73 | $15,940 | $8,967 | 56.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 89 | $13,725 | $7,864 | 57.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 59 | 59 | $11,096 | $5,969 | 53.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 65 | 82 | $7,850 | $2,861 | 36.4% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 56 | 62 | $16,700 | $1,905 | 11.4% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 39 | 46 | $2,805 | $1,203 | 42.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 43 | 58 | $1,450 | $675.71 | 46.6% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 23 | 24 | $648.00 | $391.25 | 60.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 13 | $430.00 | $134.84 | 31.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 22 | 24 | $96.00 | $53.22 | 55.4% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 26 | 120 | $120.00 | $42.99 | 35.8% |
About Dr. Albert Kashanian, M.D
Dr. Albert Kashanian, M.D is a Internal Medicine healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2010. The National Provider Identifier (NPI) number assigned to this provider is 1578894911.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Albert Kashanian, M.D has received a total of $560.50 in payments from pharmaceutical and medical device companies, with $109.66 received in 2024. These payments were reported across 27 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($560.50).
As a Medicare-enrolled provider, Kashanian has provided services to 9,325 Medicare beneficiaries, totaling 10,744 services with total Medicare billing of $533,494. Data is available for 4 years (2020–2023), covering 109 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Pasadena, CA
- Active Since 01/25/2010
- Last Updated 07/12/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1578894911
Products in Payments
- TRELEGY ELLIPTA (Drug) $187.93
- Superion Indirect Decompression System (Device) $84.31
- Xofluza (Drug) $51.68
- BREO (Drug) $46.65
- PAXLOVID (Drug) $33.27
- THINPREP 2000 PROCESSOR (Device) $25.36
- AFFIRM PRONE BIOPSY SYSTEM (Device) $24.34
- Baxdela (Drug) $22.06
- APTIMA (Device) $21.89
- Ryaltris (Drug) $21.34
- Xhance (Drug) $12.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pasadena
Dr. Yuan Yuan, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $523,801
Internal Medicine $523,801
Christopher Dagher, M.d, M.D
Internal Medicine — Payments: $103,615
Internal Medicine $103,615
Peter Haddad, M.d, M.D
Internal Medicine — Payments: $87,600
Internal Medicine $87,600
Dr. Andrew Williams, M.d, M.D
Internal Medicine — Payments: $85,273
Internal Medicine $85,273
Joseph Dellinger, Md, MD
Internal Medicine — Payments: $77,175
Internal Medicine $77,175
Dr. Helen Moon, M.d, M.D
Internal Medicine — Payments: $61,882
Internal Medicine $61,882